• Company
    • About STADA
    • Management
    • Our Corporate Culture
    • STADA worldwide
    • Company History
    • Compliance
  • Products
    • Consumer Healthcare Products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Financial Publications
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Press Photos
    • STADA Health Report
    • Social Media
    • Media Contact
  • Career
    • Purpose, Vision, and Values
    • Your Growth Journey
    • Your Benefits
    • Our Application Process
en-GB
  • DeutschDeutsch (DE-DE)
  • Company
    • About STADA
    • Management
    • Our Corporate Culture
    • STADA worldwide
    • Company History
    • Compliance
  • Products
    • Consumer Healthcare Products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Financial Publications
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Press Photos
    • STADA Health Report
    • Social Media
    • Media Contact
  • Career
    • Purpose, Vision, and Values
    • Your Growth Journey
    • Your Benefits
    • Our Application Process
  1. Press Releases
  2. All
  3. 2013

2013

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Ad hoc ReleasesPress ReleasesAll

All 2013 releases

FOLLOW US
PRODUCTS
Nizoral® Grippostad® Lunestil® Immunology Nephrology Neurology
COMPANY
About us Products Investors Media Career STADA Worldwide
GET IN TOUCH
Contact info@stada.de +49 6101 603-0 Compliance Reporting Portal ⧉
  • Conditions of Use
  • Privacy Policy
  • Imprint
  • Cookie Settings
Progenerika | © Copyright STADA Arzneimittel AG 2025